Featuring: Dan Portnoy, UC Berkeley, Tom Dubensky, Aduro Biotech, Gerald Pier, Harvard, and Vu Truong, Aridis Pharmaceuticals, Jay Keasling, UC Berkeley, Chris Paddon, Amyris
This summer, antibody therapies made headlines when one unpublished cocktail, ZMapp, was offered compassionately to several Ebola virus patients. Dr. Saphire describes the antigenic target of these antibodies, how they function against Ebola virus, and the genesis of a global consortium to develop these therapeutics.